Qube Research & Technologies LTD Century Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.19 - $5.32 $1,039 - $1,734	326 Added 4075.0%	334 $1,000
Q4 2023 Feb 13, 2024	BUY	$1.28 - $3.32 $10 - $26	8 New	8 $0
Q4 2022 Feb 14, 2023	BUY	$4.84 - $11.58 $51,458 - $123,118	10,632 New	10,632 $54,000
Q3 2021 Nov 12, 2021	SELL	$20.8 - $31.93 $415,563 - $637,929	-19,979 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$22.45 - $29.34 $448,528 - $586,183	19,979 New	19,979 $586,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $61.8M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.